Navigation Links
Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
Date:1/12/2009

se

A Phase 2 clinical trial of Plicera in Gaucher patients is ongoing. This 6 month study is designed to evaluate safety as well as to demonstrate trends of efficacy as measured by the standard endpoints in Gaucher disease. Target enrollment of 16 patients for this study is expected to be surpassed and the results are expected to be available in the third quarter of 2009.

In addition, Amicus is working closely with its partner Shire HGT to prepare for Phase 3 development of Plicera pending the results of the ongoing Phase 2 trial.

AT2220 (1-deoxynojirimycin HCl) for the treatment of Pompe Disease

A Phase 2 clinical trial of AT2220 in adult Pompe patients is ongoing. The trial includes an 11 week treatment period with an optional extension study. The objectives of the trial include the evaluation of the safety and pharmacodynamics of multiple doses and regimens of AT2220. The results of this study are expected to be available in the second half of 2009.

In addition, Amicus is continuing to conduct preclinical animal studies to evaluate the effects of administering AT2220 in combination with ERT. Encouraging preliminary results were announced at the American Society of Human Genetics conference in November 2008. These results indicated that AT2220 in combination with ERT significantly increases the stability and tissue uptake of ERT. Amicus is conducting additional preclinical proof-of-concept studies to determine the feasibility of a combination that may be appropriate for Pompe patients who are not amenable to chaperone monotherapy. Amicus expects to announce additional results in the first quarter of 2009.

2009 FINANCIAL GUIDANCE

Amicus expects to spend a total of approximately $70 million on 2009 cash operating expenses, to be offset by $50 million in program cost-sharing reimbursements and clinical milestone payments from Shire. Amicus
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
2. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
3. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
4. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
5. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
6. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
7. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
10. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
11. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... The Global Breast Pumps Market is ... an estimated CAGR of 7.6% from 2014 to 2020, according ... of innovative technologies including hand free breast pumps, growing women ... advantages of breast milk are expected to drive breast pump ... untapped growth opportunities in emerging markets such as ...
(Date:7/7/2015)... China , July 7, 2015 /PRNewswire/ -- Mindray ... a leading developer, manufacturer and marketer of medical ... acquire the remaining stake in Wuhan Dragonbio Surgical ... Dragonbio is a domestic medical ... and other surgical products. Prior to today,s announcement, ...
(Date:7/7/2015)... July 7, 2015 EnteroMedics Inc. (NASDAQ: ... use neuroblocking technology to treat obesity, metabolic diseases, and ... announced public offering of 32,000,000 units. Each unit consists of ... warrant to purchase one share of common stock at ... purchase of units in the offering would result in ...
Breaking Medicine Technology:Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
(Date:7/7/2015)... ... July 07, 2015 , ... WiseWear®, a ... launched their first line of luxury smart jewelry called the Socialite™ collection. The ... ship this fall. , “The Socialite collection was crafted to inspire women ...
(Date:7/7/2015)... ... 07, 2015 , ... Leading healthcare consulting firm Hammes Company ... Vice President, heading the firm’s Healthcare Advisory Services division. , Mr. Warden will ... providers’ needs in ways that strengthen their position in the marketplace. The Healthcare ...
(Date:7/7/2015)... ... July 07, 2015 , ... More than ... Dial and Howdy’s, raised more than $524,286 during the Muscular Dystrophy Association's ... $100,000, to help support children fighting muscular dystrophy and related life-threatening diseases ...
(Date:7/7/2015)... New York, NY (PRWEB) , ... July 07, 2015 , ... ... only thing that can help pass those long, stressful days at work is knowing ... vacations aren’t always as laid back and stress free as imagined. Planning for a ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... services, is debuting their brand new website. The website’s goal is to provide ... wider selection of patient tools, including requesting appointments online. , Part of the ...
Breaking Medicine News(10 mins):Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2
... , SARASOTA, Fla. , Feb. 10 ... is retaining new auditors. This will allow the company to complete the ... become current in its filings to the SEC. , The company would ... January 29th 2010 pursuant to the Form 8K filing. In ...
... understand what factors may influence who contracts tuberculosis (TB)/HIV co-infection ... makeup of the disease, with the majority of cases now ... paper, "HIV and Tuberculosis Co-infection Among Hispanics in Southern California: ... of the American Journal of Public Health. ...
... have double the odds of dying before age 55, study ... are at a greater risk of dying young, a new ... likely to die before age 55 as are normal-weight children. ... leave behind young families, this poses a multigenerational, societal problem, ...
... the eating disorder , WEDNESDAY, Feb. 10 (HealthDay News) -- ... of fat in their bone marrow, U.S. researchers have found. ... extremely low body weight and an obsessive fear of weight ... with almost no subcutaneous [below the skin] fat would be ...
... data from lower Manhattan residents suggest a link, nearly ... -- Nearly 10 years after the 9/11 attacks, residents ... World Trade Center site appear prone to persistent, sometimes ... preliminary," stressed study author Dr. Sara C. Crystal, an ...
... ... documents and,drawings. , ... (PRWEB) February 10, 2010 -- McLaren Software , a leader in asset information management ... ARC Advisory World Industry Forum in Orlando, Florida., , ,Due for release in March 2010, ...
Cached Medicine News:Health News:Whitemark Homes Inc. Announces Change of Auditors and Additional Corporate Information 2Health News:Burden of HIV/TB infections increasingly falling on Hispanic community 2Health News:Premature Death Could Await Obese Kids 2Health News:Premature Death Could Await Obese Kids 3Health News:With Anorexia, Body May Hoard Fat in Bones 2Health News:Exposure to 9/11 Fumes Tied to Chronic Headaches 2Health News:Exposure to 9/11 Fumes Tied to Chronic Headaches 3Health News:McLaren Software Extends the Reach of Asset Document Management Processes 2
Bausch & Lomb SofLens59 contact lenses combine excellent performance, comfort and visual acuity providing daily wear for two week replacement....
... Naugle uses reflection mirrors to measure ... even after tumor removal or thyroid ... The Naugle is easy to handle- ... comfort, and plastic mounts that are ...
Hertel exophthalmometer is used for precise exophthalmos measurements (e.g. exophthalmic goiter)....
Fastest, easiest and least expensive method for measuring exophthalmos. By sighting at right angles, this device eliminates parallax and allows the clinician to measure the amount of protrusion or bu...
Medicine Products: